A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

doi:10.1084/jem.174.6.1483

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Peppel, K.
	Articles by Beutler, B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Peppel, K.
	Articles by Beutler, B.


Social Bookmarking

	What's this?

ARTICLES

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

K Peppel, D Crawford and B Beutler
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75235.

Using a multistep polymerase chain reaction method, we have produced a construct in which a cDNA sequence encoding the extracellular domain of the human 55-kD tumor necrosis factor (TNF) receptor is attached to a sequence encoding the Fc portion and hinge region of a mouse IgG1 heavy chain through an oligomer encoding a thrombin-sensitive peptide linker. This construct was placed downstream from a cytomegalovirus promoter sequence, and expressed in Chinese hamster ovary cells. A secreted protein, capable of binding TNF and inactivating it, was produced by the transfected cells. Molecular characterization revealed that this soluble version of the TNF receptor was dimeric. Moreover, the protein could be quantitatively cleaved by treatment with thrombin. However, the monovalent extracellular domain prepared in this way has a greatly reduced TNF inhibitory activity compared with that of the bivalent inhibitor. Perhaps because of its high affinity for TNF, the chimeric protein is far more effective as a TNF inhibitor than are neutralizing monoclonal antibodies. This molecule may prove very useful as a reagent for the antagonism and assay of TNF and lymphotoxin from diverse species in health and disease, and as a means of deciphering the exact mechanism through which TNF interacts with the 55-kD receptor.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Grunewald, J., Tsao, M.-L., Perera, R., Dong, L., Niessen, F., Wen, B. G., Kubitz, D. M., Smider, V. V., Ruf, W., Nasoff, M., Lerner, R. A., Schultz, P. G. (2008). Immunochemical termination of self-tolerance. Proc. Natl. Acad. Sci. USA 105: 11276-11280 [Abstract] [Full Text]
Adriaansen, J, Khoury, M, de Cortie, C J, Fallaux, F J, Bigey, P, Scherman, D, Gould, D J, Chernajovsky, Y, Apparailly, F, Jorgensen, C, Vervoordeldonk, M J B M, Tak, P P (2007). Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis 66: 1143-1150 [Abstract] [Full Text]
Rapaka, R. R., Goetzman, E. S., Zheng, M., Vockley, J., McKinley, L., Kolls, J. K., Steele, C. (2007). Enhanced Defense against Pneumocystis carinii Mediated by a Novel Dectin-1 Receptor Fc Fusion Protein. J. Immunol. 178: 3702-3712 [Abstract] [Full Text]
Krysov, S. V., Rowley, T. F., Al-Shamkhani, A. (2007). Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells. Molecular Cancer Therapeutics 6: 703-711 [Abstract] [Full Text]
Rutschmann, S., Hoebe, K., Zalevsky, J., Du, X., Mann, N., Dahiyat, B. I., Steed, P., Beutler, B. (2006). PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-{alpha} (Tnf), Does Not Impair Lymphoid Development.. J. Immunol. 176: 7525-7532 [Abstract] [Full Text]
Mukherjee, P, Yang, S-Y, Wu, B, Song, Z, Myers, L K, Robbins, P D, Wooley, P H (2005). Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice. Ann Rheum Dis 64: 1550-1556 [Abstract] [Full Text]
El-Hayek, J. M., Rogers, T. E., Brown, G. R. (2005). The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. J. Leukoc. Biol. 78: 1001-1007 [Abstract] [Full Text]
Murali, R., Cheng, X., Berezov, A., Du, X., Schon, A., Freire, E., Xu, X., Chen, Y. H., Greene, M. I. (2005). Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107. Proc. Natl. Acad. Sci. USA 102: 10970-10975 [Abstract] [Full Text]
Brown, G. R., Lee, E. L., El-Hayek, J., Kintner, K., Luck, C. (2005). IL-12-Independent LIGHT Signaling Enhances MHC Class II Disparate CD4+ T Cell Alloproliferation, IFN-{gamma} Responses, and Intestinal Graft-versus-Host Disease. J. Immunol. 174: 4688-4695 [Abstract] [Full Text]
Peppel, K., Zhang, L., Orman, E. S., Hagen, P.-O., Amalfitano, A., Brian, L., Freedman, N. J. (2005). Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc Res 65: 674-682 [Abstract] [Full Text]
Murphy, C. C., Greiner, K., Plskova, J., Duncan, L., Frost, A., Isaacs, J. D., Rebello, P., Waldmann, H., Hale, G., Forrester, J. V., Dick, A. D. (2004). Neutralizing Tumor Necrosis Factor Activity Leads to Remission in Patients With Refractory Noninfectious Posterior Uveitis. Arch Ophthalmol 122: 845-851 [Abstract] [Full Text]
Greiner, K., Murphy, C. C., Willermain, F., Duncan, L., Plskova, J., Hale, G., Isaacs, J. D., Forrester, J. V., Dick, A. D. (2004). Anti-TNF{alpha} Therapy Modulates the Phenotype of Peripheral Blood CD4+ T Cells in Patients with Posterior Segment Intraocular Inflammation. IOVS 45: 170-176 [Abstract] [Full Text]
Mukherjee, P, Wu, B, Mayton, L, Kim, S-H, Robbins, P D, Wooley, P H (2003). TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis. Ann Rheum Dis 62: 707-714 [Abstract] [Full Text]
Lipton, A., Ali, S. M., Leitzel, K., Chinchilli, V., Witters, L., Engle, L., Holloway, D., Bekker, P., Dunstan, C. R. (2002). Serum Osteoprotegerin Levels in Healthy Controls and Cancer Patients. Clin. Cancer Res. 8: 2306-2310 [Abstract] [Full Text]
Bertry-Coussot, L., Lucas, B., Danel, C., Halbwachs-Mecarelli, L., Bach, J.-F., Chatenoud, L., Lemarchand, P. (2002). Long-Term Reversal of Established Autoimmunity upon Transient Blockade of the LFA-1/Intercellular Adhesion Molecule-1 Pathway. J. Immunol. 168: 3641-3648 [Abstract] [Full Text]
Childs, L. M., Goater, J. J., O'Keefe, R. J., Schwarz, E. M. (2001). Effect of Anti-Tumor Necrosis Factor-{alpha} Gene Therapy on Wear Debris-Induced Osteolysis. JBJS 83: 1789-1797 [Abstract] [Full Text]
Forlow, S. B., Schurr, J. R., Kolls, J. K., Bagby, G. J., Schwarzenberger, P. O., Ley, K. (2001). Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 98: 3309-3314 [Abstract] [Full Text]
Rayner, S. A., Larkin, D. F. P., George, A. J. T. (2001). TNF Receptor Secretion after Ex Vivo Adenoviral Gene Transfer to Cornea and Effect on In Vivo Graft Survival. IOVS 42: 1568-1573 [Abstract] [Full Text]
Kadokami, T., McTiernan, C. F., Kubota, T., Frye, C. S., Bounoutas, G. S., Robbins, P. D., Watkins, S. C., Feldman, A. M. (2001). Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression. Am. J. Physiol. Heart Circ. Physiol. 280: H2281-H2291 [Abstract] [Full Text]
Behrens, C. K., Igney, F. H., Arnold, B., Moller, P., Krammer, P. H. (2001). CD95 Ligand-Expressing Tumors Are Rejected in Anti-Tumor TCR Transgenic Perforin Knockout Mice. J. Immunol. 166: 3240-3247 [Abstract] [Full Text]
Darville, T., Andrews, C. W. Jr., Rank, R. G. (2000). Does Inhibition of Tumor Necrosis Factor Alpha Affect Chlamydial Genital Tract Infection in Mice and Guinea Pigs?. Infect. Immun. 68: 5299-5305 [Abstract] [Full Text]
Quattrocchi, E., Walmsley, M., Browne, K., Williams, R. O., Marinova-Mutafchieva, L., Buurman, W., Butler, D. M., Feldmann, M. (1999). Paradoxical Effects of Adenovirus-Mediated Blockade of TNF Activity in Murine Collagen-Induced Arthritis. J. Immunol. 163: 1000-1009 [Abstract] [Full Text]
Jimi, E., Akiyama, S., Tsurukai, T., Okahashi, N., Kobayashi, K., Udagawa, N., Nishihara, T., Takahashi, N., Suda, T. (1999). Osteoclast Differentiation Factor Acts as a Multifunctional Regulator in Murine Osteoclast Differentiation and Function. J. Immunol. 163: 434-442 [Abstract] [Full Text]
Alcami, A, Khanna, A, Paul, N., Smith, G. (1999). Vaccinia virus strains Lister, USSR and Evans express soluble and cell- surface tumour necrosis factor receptors. J. Gen. Virol. 80: 949-959 [Abstract]
Smith, S., Skerrett, S. J., Chi, E. Y., Jonas, M., Mohler, K., Wilson, C. B. (1998). The locus of tumor necrosis factor-alpha action in lung inflammation.. Am. J. Respir. Cell Mol. Bio. 19: 881-891 [Abstract] [Full Text]
Cheung, A. T., Ree, D., Kolls, J. K., Fuselier, J., Coy, D. H., Bryer-Ash, M. (1998). An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-{alpha} (TNF-{alpha})-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-{alpha}. Endocrinology 139: 4928-4935 [Abstract] [Full Text]
Croxford, J. L., Triantaphyllopoulos, K., Podhajcer, O. L., Feldmann, M., Baker, D., Chernajovsky, Y. (1998). Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System. J. Immunol. 160: 5181-5187 [Abstract] [Full Text]
Loparev, V. N., Parsons, J. M., Knight, J. C., Panus, J. F., Ray, C. A., Buller, R. M. L., Pickup, D. J., Esposito, J. J. (1998). A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA 95: 3786-3791 [Abstract] [Full Text]
Yamaguchi, K., Kinosaki, M., Goto, M., Kobayashi, F., Tsuda, E., Morinaga, T., Higashio, K. (1998). Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor. J. Biol. Chem. 273: 5117-5123 [Abstract] [Full Text]
Osuga, Y., Kudo, M., Kaipia, A., Kobilka, B., Hsueh, A. J. W. (1997). Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors. Mol. Endocrinol. 11: 1659-1668 [Abstract] [Full Text]
Schneider, P., Bodmer, J.-L., Holler, N., Mattmann, C., Scuderi, P., Terskikh, A., Peitsch, M. C., Tschopp, J. (1997). Characterization of Fas (Apo-1, CD95)-Fas Ligand Interaction. J. Biol. Chem. 272: 18827-18833 [Abstract] [Full Text]
Turnbull, A. V., Pitossi, F. J., Lebrun, J.-J., Lee, S., Meltzer, J. C., Nance, D. M., del Rey, A., Besedovsky, H. O., Rivier, C. (1997). Inhibition of Tumor Necrosis Factor-alpha Action within the CNS Markedly Reduces the Plasma Adrenocorticotropin Response to Peripheral Local Inflammation in Rats. J. Neurosci. 17: 3262-3273 [Abstract] [Full Text]
Al-Shamkhani, A., Mallett, S., Brown, M. H., James, W., Barclay, A. N. (1997). Affinity and Kinetics of the Interaction between Soluble Trimeric OX40 Ligand, a Member of the Tumor Necrosis Factor Superfamily, and Its Receptor OX40 on Activated T Cells. J. Biol. Chem. 272: 5275-5282 [Abstract] [Full Text]
Bazzoni, F., Beutler, B. (1996). The Tumor Necrosis Factor Ligand and Receptor Families. NEJM 334: 1717-1725 [Full Text]
Schreiber, M., Rajarathnam, K., McFadden, G. (1996). Myxoma Virus T2 Protein, a Tumor Necrosis Factor (TNF) Receptor Homolog, Is Secreted as a Monomer and Dimer That Each Bind Rabbit TNFalpha , but the Dimer Is a More Potent TNF Inhibitor. J. Biol. Chem. 271: 13333-13341 [Abstract] [Full Text]
Porat, R., Paddock, H.N., Cominelli, F., Marra, M.N., Scott, R.W., Schwaitzberg, S.D., Dinarello, C.A. (1995). Effects of bactericidal/permeability-increasing protein on endotoxin-induced fever and Escherichia coli-induced shock in rabbits. Innate Immunity 2: 9-18 [Abstract]
Crowe, P., VanArsdale, T., Walter, B., Ware, C., Hession, C, Ehrenfels, B, Browning, J., Din, W., Goodwin, R., Smith, C. (1994). A lymphotoxin-beta-specific receptor. Science 264: 707-710 [Abstract]